Advances in PET Imaging of the CXCR4 Receptor:[68Ga] Ga-PentixaFor
L Lindenberg, M Ahlman, F Lin, E Mena… - Seminars in Nuclear …, 2023 - Elsevier
[68 Ga] Ga-PentixaFor, a PET agent targeting CXCR4 is emerging as a versatile radiotracer
with promising applications in oncology, cardiology and inflammatory disease. Preclinical …
with promising applications in oncology, cardiology and inflammatory disease. Preclinical …
The cutting edge: Promising oncology radiotracers in clinical development
Molecular imaging moves forward with the development of new imaging agents, and among
these are new radiotracers for nuclear medicine applications, particularly positron emission …
these are new radiotracers for nuclear medicine applications, particularly positron emission …
[HTML][HTML] CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology
N Dreher, S Hahner, CT Fuß, W Schlötelburg… - European Journal of …, 2024 - Springer
Background CXC motif chemokine receptor 4 (CXCR4) is overexpressed in various solid
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …
cancers and can be targeted by CXCR4-directed molecular imaging. We aimed to …
[HTML][HTML] Predictive value of CXC motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma
W Schloetelburg, PE Hartrampf, A Kosmala… - European Journal of …, 2024 - Springer
Background In patients affected with adrenocortical carcinoma (ACC), CXC motif chemokine
receptor 4 (CXCR4) is highly expressed in sites of disease in an ex-vivo setting. We aimed …
receptor 4 (CXCR4) is highly expressed in sites of disease in an ex-vivo setting. We aimed …
Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies
Advancements in somatostatin receptor (SSTR) targeted imaging and treatment of well-
differentiated neuroendocrine tumors (NETs) have revolutionized the management of these …
differentiated neuroendocrine tumors (NETs) have revolutionized the management of these …
Performance evaluation of Gallium-68 radiopharmaceuticals production using liquid target PETtrace 800 cyclotron
Due to increased demand, cyclotron has an expanding role in producing Gallium-68 (68 Ga)
radiopharmaceuticals using solid and liquid targets. Though the liquid target produces lower …
radiopharmaceuticals using solid and liquid targets. Though the liquid target produces lower …
[HTML][HTML] Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas
K Michalski, W Schlötelburg, P Hartrampf… - Molecular Imaging and …, 2024 - Springer
Background Gastro-entero-pancreatic neuroendocrine carcinomas (GEP-NECs) are an
aggressive subgroup of neuroendocrine neoplasms (NENs). In patients affected with NEN …
aggressive subgroup of neuroendocrine neoplasms (NENs). In patients affected with NEN …
Primäre und sekundäre Lebertumore–aus Sicht der Nuklearmedizin
A Holzgreve, H Ilhan, LM Unterrainer… - Angewandte …, 2023 - thieme-connect.com
Konventionelle, radiologische Modalitäten wie die Ultraschalldiagnostik, CT-und MRT-
Bildgebung sind der klinische Standard in der onkologischen Bildgebung primärer und …
Bildgebung sind der klinische Standard in der onkologischen Bildgebung primärer und …